Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea
Sponsor: Pfizer
Summary
The purpose of this study is to evaluate safety and effectiveness of NURTEC® ODT 75 mg (Rimegepant sulfate) in adult patients with acute treatment of migraine with or without aura and with preventive treatment of episodic migraine during the PMS period as required by the Korean ministry of food and drug safety (MFDS).
Official title: A Post-marketing Surveillance (PMS) Study to Evaluate the Safety and Effectiveness of NURTEC® ODT 75 mg (Rimegepant Sulfate) in Adult Migraine Patients in Korea.
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
3000
Start Date
2026-10-01
Completion Date
2030-08-01
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
Rimegepant sulfate
ALL Who treated with Rimegepant sulfate